The 13th International Symposium of Targeted Alpha Therapy is cancelled

Dear colleagues,

We are very sorry to inform you that the 13th International Symposium of Targeted Alpha Therapy originally planned to be held in Oslo in May 2025 has to be cancelled due to an amalgamation of several organizational and financial issues faced by the local Norwegian organizers.

In response to these recent developments, the Joint Research Centre of the European Commission as main organizer of the very successful series of TAT symposia is presently exploring opportunities to postpone TAT’13 and to conduct it in an alternative setting at later time. We will keep you informed on any developments in this regard.

In the meantime, we thank you for your support of TAT’13 and for your understanding. We apologize for any inconvenience this change may have created and look forward to future opportunities to work together, fostering scientific exchange, connecting academic, clinical and industry experts and stimulating novel collaborations to advance the exciting field of targeted alpha therapy.

Kind regards,

Øyvind S. Bruland & Alfred Morgenstern